EI
KRTX

Ellevest Inc’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Ellevest Inc’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-11
Closed -$2K – 1771
2023
Q1 		$2K Buy
11
+10
+1,000% +$1.91K ﹤0.01% 1443
2022
Q4 		$197 Sell
1
-34
-97% -$7.29K ﹤0.01% 1725
2022
Q3 		$8K Buy
+35
New +$7.08K ﹤0.01% 1095

Other funds holding KRTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ellevest Inc's KRTX Position: Q2 2023 in Review

Ellevest Inc sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q2 2023, closing a stake of 11 shares — an estimated $2K sold.

Ellevest Inc first reported a position in KRTX in Q3 2022 and held it in 3 quarters. The position peaked at $8K in Q3 2022. 289 funds tracked by Wall St. Rank hold KRTX as of Q2 2023.

  • Ellevest Inc reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Ellevest Inc sold 11 Karuna Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $2K.
  • Ellevest Inc first reported a position in Karuna Therapeutics, Inc. Common Stock in Q3 2022 and held it in 3 quarters.
  • Ellevest Inc's Karuna Therapeutics, Inc. Common Stock position peaked at $8K in Q3 2022.
  • 289 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q2 2023.

Based on Ellevest Inc's 13F filing for Q2 2023, filed 9 Aug 2023.